Last update 22 Dec 2024

Selenium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
selenium, Selenase
Target
Mechanism
survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors)
Therapeutic Areas
Active Indication
Originator Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromePhase 3
BR
31 Oct 2008
CardiotoxicityPhase 3
BR
31 Oct 2008
Chagas DiseasePhase 3
BR
31 Oct 2008
Chronic DiseasePhase 3
BR
31 Oct 2008
end organ damagePhase 3
BR
31 Oct 2008
Functional disorderPhase 3
BR
31 Oct 2008
Huntington DiseasePhase 3
BR
31 Oct 2008
InfarctionPhase 3
BR
31 Oct 2008
Keshan DiseasePhase 3
BR
31 Oct 2008
Myocardial InfarctionPhase 3
BR
31 Oct 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Selenium supplementation
zmgclibigi(djnqkrjpzr) = kuiaskgisl rfgjjlxalm (vfnzfloqzs )
-
01 Sep 2024
Not Applicable
toenail selenium level
-
High selenium concentration
hkuoccrhmt(etpkvmnlro) = The supplementation is associated with some adverse side effects cshylydyvm (ivjkxrkbcg )
Negative
03 Nov 2022
Low selenium concentration
Not Applicable
reactive oxygen species (ROS) | miRNA-126 | CoQ10
60
qrzjennxqz(czxjzmcjwk) = bmsmbdyact mgamwblhjk (rstncxnykv )
Positive
06 Jun 2020
Phase 1
-
zztmwahipt(dcwqihdtyr) = urcpdhkheq rwqmtldtyf (glrwvffwmu )
-
01 Jul 2018
Not Applicable
120
apdvnjvjzl(tafjppshyl) = nxcvnmkocb neymxvuopx (oorvpecnkc )
Negative
18 May 2018
(Placebo)
apdvnjvjzl(tafjppshyl) = ltnzclezll neymxvuopx (oorvpecnkc )
Not Applicable
Hypertension
selenium deficiency
-
Selenium supplement (500 ug sodium selenite)
iosrwjzjeq(zcnpdntyxv) = wpidyjxoed junmtovhcb (qsbkczceee )
Positive
01 Sep 2016
Not Applicable
Hemodialysis complication
selenium levels | T3 | free T4 ...
40
(Brazil nut supplementation)
rrmzcxudbw(ujfpbasvrv) = ozyzyagsem nptroulung (pkdbzzuykx, 11.2)
Positive
21 May 2015
Not Applicable
-
-
Selenium administration + RIT
ogpzlmkris(riwzauseey) = euluwuvonf onkdniasxi (esrhzfrdcu, 57.0 - 91.0)
-
15 May 2015
Not Applicable
463
Selenium supplementation
fkuzqiorbe(ypgbyrtpxd): RR = 4.67 (95% CI, 1.61 - 13.5), P-Value = 0.004
-
06 Jun 2013
Not Applicable
67
nxdqmwshez(rnunqbcvyi) = akjurtjspy myooycfnjf (vbznzyafxl )
-
20 May 2011
nxdqmwshez(rnunqbcvyi) = juhsgjfwxj myooycfnjf (vbznzyafxl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free